| Term 
 | Definition 
 
        | Blocks DHFR; long lasting Part of CMF
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incorporated in DNA and blocks DNA replication because Thymidilate Synthase cant add methyl to C5 Part of CMF
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cyclophosphamide, Methotrexate, 5-Fluro-Uracil |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analog of 5-FU but replaces Cytidine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | (Adriamycin)Topoisomerase Inhib. Used in Breast cancer; cardiotoxic (dose dependent/ F>M)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Topoisomerase Inhib. used in colorectal cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alkylating agent use in Lung and Ovarian cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DNA alkylating agent Oral prodrug(no tissue damage)
 May cause leukopenia or secondary cancer
 Used in CMF
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks microtubule formation (Spindle poison) may cause peripheral neurotoxicity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks microtubule disassembly (Spindle poison) may cause peripheral neuropathy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Humanized mAb against VEGF to block angiogenesis Causes HTN (damaged endothelium)
 Low efficacy so used to get cytotoxic drugs into tumor and prevent angiogenesis in macular degeneration
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cyclophosphamide, Hydroxydaunorubin(Doxorubicin/Adriamycin), Oncovin(Vincristine), and Prednisone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chimeric mAb against CD20 on Bcells Improves Overall survival and disease free survival in Bcell Lymphomas when used with CHOP
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Human mAb against EGF-R with less immunogenicity that Cetuximab IgG2 so no C' or FcR affinity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chimeric mAb against EGF-R(HER1) Used in WT Kras Colorectal Cancer
 Side effects are rash and diarrhea(EGF-R is in skin and GI tract)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Humanized mAb against HER2 used in agressive HER2+ breast cancers Increases survival
 Cardiotoxic (HER2 is on cardiomyocytes)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chimeric mAb against CD25(IL2R) Immunosuppressent
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Humanized mAb against CD25(IL2R) Immunisuppressent
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Binds mTOR and inhibits activation of Tcells by IL2 Immunosuppressant
 |  | 
        |  | 
        
        | Term 
 
        | Cyclosporine and Tacrolimus |  | Definition 
 
        | Bind calcineurin which inhibits IL2R and blocks Tcell proliferation Immunosuppressant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prodrug of mercaptopurine; inserts mercaptopurine in DNA and blocks replication Immunosuppressant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Preotease Inhibitor that causes apoptosis Used in Multiple Myeloma
 Side affects are GI and neutropenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Broad Spectrum inhibitors mainly acting on VEGFR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Broad Spectrum inhibitors mainly acting on VEGFR |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Gleevac Targets bcr/abl fusion protein in CML
 Resistanc develops fast
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | EGFR Kinase inhibitor Commonly used in lung cancer
 Side affect is rash
 Some lung cancers are resistant
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | EGFR Kinase inhibitor Used commonly in lung cancer
 Side effect is rash
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic and Anti-inflammatory; OTC Unstable angina/ Post MI (Because its irreversible)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic only; OTC Weak base, 20%bound, weak COX-I (low AI)
 No effect on uterine contractions
 Safe in children, pregnancy, renal disease, asthmatics, bleeding disorders
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic and Anti-inflammatory; OTC Best for primary dysmenorrhea
 Lowest GI risk
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic and Anti-inflammatory; OTC Higher ceiling and T1/2 than Aspirin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic and Anti-inflammatory; OTC Higher Ceiling than Aspirin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic and Anti-inflammatory (salicylate) Higher efficacy/analgesic ceiling and half life than aspirin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-inflammatory only Prodrug; Active sulfide metabolite
 Used in renal complications
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-inflammatory only Highest COX1-I potency
 PDA in neonates
 Most potent COX1 Inhib (Most POTENT AI)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Anti-inflammatory only COX2 Selective
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Analgesic and Anti-inflammatory COX2 Selective
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Methylated PGE1 Analogue Restores GI prostagladins and protects against GI sideeffects of NSAIDS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antidote to Acetaminophen poisoning |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Short acting glucocorticoid(8-12hrs) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Short acting glucocorticoid(8-12hrs) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Potent mineralocorticoid 9alpha-fluoro
 8-12 hrs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Short acting glucocorticoid 8-12hrs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Intermediate acting glucocorticoid (12-36hrs) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Long acting glucocorticoid (36-72hrs) A ring double bond=higher GC activity
 Methyl on C6=higher GC potency and longer half life
 Methyl on C16 on D ring=decreased MC activity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks 1st step in steroid biosynthesis (Cholesterol to Pregnenolone) Blocks all steroid production
 Used in Cushings
 Chemical Adrenectomy
 ACTH rises
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Blocks last step of Cortisol syn and syn of mineralcorticoids Used to test competency of adrenal axis (ACTH rises)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Induced by glucocorticoids Blcoks lipooxygenase and Cox
 will not cross react with NSAID hypersensitivity
 |  | 
        |  |